Higly active Ansamitocin analogues for tumor therapy
The invention comprises designed novel biologically highly potent ansamitocin analogues for tumor therapy, inlcuding among other new 19-deschloro and demethoxy derivatives of known AP-3 ansamitocin, showing a strong inhibitory effect on cell growth. They could be the basis for a cancer therapy, and might show fewer side effects than the known ones tested at clinical studies.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Properties of new materials for microchips
… can now be measured well. Reseachers of Delft University of Technology demonstrated measuring performance properties of ultrathin silicon membranes. Making ever smaller and more powerful chips requires new ultrathin…
Floating solar’s potential
… to support sustainable development by addressing climate, water, and energy goals holistically. A new study published this week in Nature Energy raises the potential for floating solar photovoltaics (FPV)…
Skyrmions move at record speeds
… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…